Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania

Abstract Background Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the consequences of malaria during pregnancy. This s...

Full description

Bibliographic Details
Main Authors: Wigilya P. Mikomangwa, Omary Minzi, Ritah Mutagonda, Vito Baraka, Eulambius M. Mlugu, Eleni Aklillu, Appolinary A. R. Kamuhabwa
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Malaria Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12936-020-03234-4
_version_ 1819050490829209600
author Wigilya P. Mikomangwa
Omary Minzi
Ritah Mutagonda
Vito Baraka
Eulambius M. Mlugu
Eleni Aklillu
Appolinary A. R. Kamuhabwa
author_facet Wigilya P. Mikomangwa
Omary Minzi
Ritah Mutagonda
Vito Baraka
Eulambius M. Mlugu
Eleni Aklillu
Appolinary A. R. Kamuhabwa
author_sort Wigilya P. Mikomangwa
collection DOAJ
description Abstract Background Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the consequences of malaria during pregnancy. This study assessed the effect of IPTp-SP for prevention of malaria during pregnancy in low transmission settings. Methods A cross-sectional study that involved consecutively selected 1161 pregnant women was conducted at Mwananyamala regional referral hospital in Dar es Salaam. Assessment of the uptake of IPTp-SP was done by extracting information from antenatal clinic cards. Maternal venous blood, cord blood, placental blood and placental biopsy were collected for assessment of anaemia and malaria. High performance liquid chromatography with ultraviolet detection (HPLC-UV) was used to detect and quantify sulfadoxine (SDX). Dried blood spots (DBS) of placental blood were collected for determination of sub-microscopic malaria using polymerase chain reaction (PCR). Results In total, 397 (34.2%) pregnant women reported to have used sub-optimal doses (≤ 2) while 764 (65.8%) used optimal doses (≥ 3) of IPTp-SP at the time of delivery. The prevalence of placental malaria as determined by histology was 3.6%. Submicroscopic placental malaria was detected in 1.4% of the study participants. Women with peripheral malaria had six times risk of maternal anaemia than those who were malaria negative (aOR, 5.83; 95% CI 1.10–30.92; p = 0.04). The geometric mean plasma SDX concentration was 10.76 ± 2.51 μg/mL. Sub-optimal IPTp-SP dose was not associated with placental malaria, premature delivery and fetal anaemia. The use of ≤ 2 doses of IPTp-SP increased the risk of maternal anaemia by 1.36-fold compared to ≥ 3 doses (aOR, 1.36; 95% CI 1.04–1.79; p = 0.02). Conclusion The use of < 2 doses of IPTp-SP increased the risk of maternal anaemia. However, sub-optimal doses (≤ 2 doses) were not associated with increased the risk of malaria parasitaemia, fetal anaemia and preterm delivery among pregnant women in low malaria transmission setting. The use of optimal doses (≥ 3 doses) of IPTp-SP and complementary interventions should continue even in areas with low malaria transmission.
first_indexed 2024-12-21T11:48:53Z
format Article
id doaj.art-7bf401209aaa4784b0904cd878e75562
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-21T11:48:53Z
publishDate 2020-04-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-7bf401209aaa4784b0904cd878e755622022-12-21T19:05:06ZengBMCMalaria Journal1475-28752020-04-0119111110.1186/s12936-020-03234-4Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in TanzaniaWigilya P. Mikomangwa0Omary Minzi1Ritah Mutagonda2Vito Baraka3Eulambius M. Mlugu4Eleni Aklillu5Appolinary A. R. Kamuhabwa6Clinical Pharmacy and Pharmacology Department, Muhimbili University of Health and Allied SciencesClinical Pharmacy and Pharmacology Department, Muhimbili University of Health and Allied SciencesClinical Pharmacy and Pharmacology Department, Muhimbili University of Health and Allied SciencesNational Institute for Medical Research, Tanga CentrePharmaceutics and Pharmacy Practice Department, Muhimbili University of Health and Allied SciencesDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital-Huddinge C1:68Clinical Pharmacy and Pharmacology Department, Muhimbili University of Health and Allied SciencesAbstract Background Malaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the consequences of malaria during pregnancy. This study assessed the effect of IPTp-SP for prevention of malaria during pregnancy in low transmission settings. Methods A cross-sectional study that involved consecutively selected 1161 pregnant women was conducted at Mwananyamala regional referral hospital in Dar es Salaam. Assessment of the uptake of IPTp-SP was done by extracting information from antenatal clinic cards. Maternal venous blood, cord blood, placental blood and placental biopsy were collected for assessment of anaemia and malaria. High performance liquid chromatography with ultraviolet detection (HPLC-UV) was used to detect and quantify sulfadoxine (SDX). Dried blood spots (DBS) of placental blood were collected for determination of sub-microscopic malaria using polymerase chain reaction (PCR). Results In total, 397 (34.2%) pregnant women reported to have used sub-optimal doses (≤ 2) while 764 (65.8%) used optimal doses (≥ 3) of IPTp-SP at the time of delivery. The prevalence of placental malaria as determined by histology was 3.6%. Submicroscopic placental malaria was detected in 1.4% of the study participants. Women with peripheral malaria had six times risk of maternal anaemia than those who were malaria negative (aOR, 5.83; 95% CI 1.10–30.92; p = 0.04). The geometric mean plasma SDX concentration was 10.76 ± 2.51 μg/mL. Sub-optimal IPTp-SP dose was not associated with placental malaria, premature delivery and fetal anaemia. The use of ≤ 2 doses of IPTp-SP increased the risk of maternal anaemia by 1.36-fold compared to ≥ 3 doses (aOR, 1.36; 95% CI 1.04–1.79; p = 0.02). Conclusion The use of < 2 doses of IPTp-SP increased the risk of maternal anaemia. However, sub-optimal doses (≤ 2 doses) were not associated with increased the risk of malaria parasitaemia, fetal anaemia and preterm delivery among pregnant women in low malaria transmission setting. The use of optimal doses (≥ 3 doses) of IPTp-SP and complementary interventions should continue even in areas with low malaria transmission.http://link.springer.com/article/10.1186/s12936-020-03234-4MalariaPregnancyIntermittent-preventive treatmentSulfadoxine-pyrimethamineAnaemiaTanzania
spellingShingle Wigilya P. Mikomangwa
Omary Minzi
Ritah Mutagonda
Vito Baraka
Eulambius M. Mlugu
Eleni Aklillu
Appolinary A. R. Kamuhabwa
Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
Malaria Journal
Malaria
Pregnancy
Intermittent-preventive treatment
Sulfadoxine-pyrimethamine
Anaemia
Tanzania
title Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
title_full Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
title_fullStr Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
title_full_unstemmed Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
title_short Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
title_sort effect of sulfadoxine pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in tanzania
topic Malaria
Pregnancy
Intermittent-preventive treatment
Sulfadoxine-pyrimethamine
Anaemia
Tanzania
url http://link.springer.com/article/10.1186/s12936-020-03234-4
work_keys_str_mv AT wigilyapmikomangwa effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT omaryminzi effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT ritahmutagonda effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT vitobaraka effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT eulambiusmmlugu effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT eleniaklillu effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania
AT appolinaryarkamuhabwa effectofsulfadoxinepyrimethaminedosesforpreventionofmalariaduringpregnancyinhypoendemicareaintanzania